ATYR News

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Pomerantz LLP Reminds Shareholders with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit – ATYR

ATYR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

aTyr Pharma (ATYR) Securities Class Action Pending Over Key Drug's Efficacy -- Hagens Berman

ATYR Deadline: ATYR Investors with Losses in Excess of $100K Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit

aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Investor Alert: Deadline Approaching to Join aTyr Pharma, Inc. (ATYR) Class Action - Contact Levi & Korsinsky

Pomerantz LLP Reminds Shareholders with Losses on their Investment in aTyr Pharma, Inc. – ATYR

ATYR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

aTyr Pharma, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights – ATYR